Overview

Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer

Status:
Withdrawn
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to determine if Iressa added to chemotherapy with Irinotecan, 5Fluorouracil and Leucovorin can prolong the period of time without any disease worsening (Time to Progression) in patients with metastatic colorectal cancer.
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca
Treatments:
Camptothecin
Fluorouracil
Gefitinib
Irinotecan
Leucovorin